Renal Cancer

Walter M. Stadler, MD · Jame Abraham, MD, FACP

ਅਪ੍ਰੈ 2011 · Demos Medical Publishing

ਇਸ ਈ-ਕਿਤਾਬ ਬਾਰੇ

This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of renal cancer treatment. Renal cancer treatment has undergone major changes over the course of the past few years and Renal Cancer addresses current best practices in the light of the most recent evidence. All of the chapters are written by international experts in the field, address the common clinical scenarios in renal cancer and are multidisciplinary in scope covering surgical, medical, and radiation therapy. Chapters examining emerging and novel therapeutic targets, the management of both CNS, and skeletal metastases in renal cancer round out the coverage. Emerging Cancer Therapeutics features:

• Editorial board of nationally recognized experts across the spectrum of Cancer Therapeutics
• In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics
• Issues edited by an authority in specific subject area
• Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
• Emphasizes multidisciplinary approaches to research and practice

ਲੇਖਕ ਬਾਰੇ

Walter M. Stadler, MD, the Fred C. Buffet Professor of Medicine, Director, Genitourinary Program; Associate Dean for Clinical Research, University of Chicago Medical Center, Chicago, IL.

Jame Abraham, MD, FACP, is Bonnie Wells Wilson Distinguised Professor and Eminent Scholar, Chief Section of Hematology - Oncology, and Medical Director, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia